Bellecapital International Ltd. Charles River Laboratories International, Inc. Transaction History

Bellecapital International Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	BUY	$191.89 - $259.92 $129,141 - $174,926	673 Added 2.86%	24,237 $4.89 Million
Q4 2022 Feb 10, 2023	BUY	$197.11 - $250.07 $131,275 - $166,546	666 Added 2.91%	23,564 $5.13 Million
Q3 2022 Nov 07, 2022	BUY	$182.44 - $250.54 $1.18 Million - $1.62 Million	6,470 Added 39.38%	22,898 $4.51 Million
Q2 2022 Jul 27, 2022	BUY	$204.13 - $302.4 $3.07 Million - $4.55 Million	15,035 Added 1079.33%	16,428 $3.52 Million
Q1 2022 May 03, 2022	SELL	$255.51 - $362.11 $6,132 - $8,690	-24 Reduced 1.69%	1,393 $396,000
Q4 2021 Jan 20, 2022	SELL	$351.38 - $448.68 $14,757 - $18,844	-42 Reduced 2.88%	1,417 $534,000
Q3 2021 Oct 21, 2021	BUY	$372.64 - $458.3 $7,080 - $8,707	19 Added 1.32%	1,459 $602,000
Q2 2021 Jul 28, 2021	BUY	$294.17 - $371.65 $11,472 - $14,494	39 Added 2.78%	1,440 $533,000
Q1 2021 Apr 13, 2021	BUY	$249.67 - $299.48 $349,787 - $419,571	1,401 New	1,401 $406,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Bellecapital International Ltd., based on Form 13F filings with the SEC.

Stay updated on Bellecapital International Ltd. with notifications on news.